Do analysts rate AMIX or MBAI?

Autonomix Medical presently has a consensus target price of $42.00, suggesting a potential upside of 482.52%. Given Autonomix Medical's stronger consensus rating and higher probable upside, analysts plainly believe Autonomix Medical is more favorable than Check-Cap. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Autonomix Medical 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Check-Cap 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better earnings & valuation, AMIX or MBAI?

Autonomix Medical is trading at a lower price-to-earnings ratio than Check-Cap, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Autonomix Medical N/A N/A -$16.72M -$3.55 N/A Check-Cap N/A N/A $4.14M -$2.77 N/A

Is AMIX or MBAI more profitable?

Check-Cap's return on equity of 0.00% beat Autonomix Medical's return on equity. Company Net Margins Return on Equity Return on Assets Autonomix Medical N/A -239.36% -192.46% Check-Cap N/A N/A N/A

Does the media favor AMIX or MBAI?

In the previous week, Autonomix Medical had 5 more articles in the media than Check-Cap. MarketBeat recorded 6 mentions for Autonomix Medical and 1 mentions for Check-Cap. Check-Cap's average media sentiment score of 0.00 beat Autonomix Medical's score of -0.50 indicating that Check-Cap is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Autonomix Medical 0 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Negative Check-Cap 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate AMIX or QNRX?

Autonomix Medical presently has a consensus price target of $42.00, suggesting a potential upside of 482.52%. Given Autonomix Medical's higher probable upside, research analysts plainly believe Autonomix Medical is more favorable than Quoin Pharmaceuticals. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Autonomix Medical 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Quoin Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has stronger valuation & earnings, AMIX or QNRX?

Autonomix Medical is trading at a lower price-to-earnings ratio than Quoin Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Autonomix Medical N/A N/A -$16.72M -$3.55 N/A Quoin Pharmaceuticals N/A N/A -$15.81M -$29.56 N/A

Is AMIX or QNRX more profitable?

Autonomix Medical's return on equity of -239.36% beat Quoin Pharmaceuticals' return on equity. Company Net Margins Return on Equity Return on Assets Autonomix Medical N/A -239.36% -192.46% Quoin Pharmaceuticals N/A -489.85% -221.29%

Does the media prefer AMIX or QNRX?

In the previous week, Autonomix Medical had 2 more articles in the media than Quoin Pharmaceuticals. MarketBeat recorded 6 mentions for Autonomix Medical and 4 mentions for Quoin Pharmaceuticals. Quoin Pharmaceuticals' average media sentiment score of 0.00 beat Autonomix Medical's score of -0.50 indicating that Quoin Pharmaceuticals is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Autonomix Medical 0 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Negative Quoin Pharmaceuticals 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to SINT or AMIX?

In the previous week, Autonomix Medical had 5 more articles in the media than Sintx Technologies. MarketBeat recorded 6 mentions for Autonomix Medical and 1 mentions for Sintx Technologies. Sintx Technologies' average media sentiment score of 0.00 beat Autonomix Medical's score of -0.50 indicating that Sintx Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Sintx Technologies 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Autonomix Medical 0 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Negative

Does the media refer more to AMIX or ALUR?

In the previous week, Autonomix Medical had 5 more articles in the media than Allurion Technologies. MarketBeat recorded 6 mentions for Autonomix Medical and 1 mentions for Allurion Technologies. Allurion Technologies' average media sentiment score of -0.18 beat Autonomix Medical's score of -0.50 indicating that Allurion Technologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Autonomix Medical 0 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Negative Allurion Technologies 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts recommend NXL or AMIX?

Autonomix Medical has a consensus price target of $42.00, indicating a potential upside of 482.52%. Given Autonomix Medical's stronger consensus rating and higher possible upside, analysts clearly believe Autonomix Medical is more favorable than Nexalin Technology. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nexalin Technology 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Autonomix Medical 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Does the media favor NXL or AMIX?

In the previous week, Autonomix Medical had 4 more articles in the media than Nexalin Technology. MarketBeat recorded 6 mentions for Autonomix Medical and 2 mentions for Nexalin Technology. Nexalin Technology's average media sentiment score of 0.36 beat Autonomix Medical's score of -0.50 indicating that Nexalin Technology is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Nexalin Technology 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Autonomix Medical 0 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Negative

Autonomix Medical (AMIX) Competitors

$7.21 -0.33 (-4.36%)

Closing price 03:54 PM Eastern

Extended Trading

$7.32 +0.12 (+1.60%)

As of 06:17 PM Eastern

Compare

AMIX vs. MBAI, QNRX, SINT, ALUR, and NXL

Should you buy Autonomix Medical stock or one of its competitors? MarketBeat compares Autonomix Medical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Autonomix Medical include Check-Cap (MBAI), Quoin Pharmaceuticals (QNRX), Sintx Technologies (SINT), Allurion Technologies (ALUR), and Nexalin Technology (NXL). These companies are all part of the "medical equipment" industry.

How does Autonomix Medical compare to Check-Cap?

Autonomix Medical (NASDAQ:AMIX) and Check-Cap (NASDAQ:MBAI) are both small-cap medical equipment companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, dividends, earnings, media sentiment, risk and profitability.

Autonomix Medical is trading at a lower price-to-earnings ratio than Check-Cap, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Autonomix Medical	N/A	N/A	-$16.72M	-$3.55	N/A
Check-Cap	N/A	N/A	$4.14M	-$2.77	N/A

Autonomix Medical presently has a consensus target price of $42.00, suggesting a potential upside of 482.52%. Given Autonomix Medical's stronger consensus rating and higher probable upside, analysts plainly believe Autonomix Medical is more favorable than Check-Cap.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Autonomix Medical	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Check-Cap	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Autonomix Medical had 5 more articles in the media than Check-Cap. MarketBeat recorded 6 mentions for Autonomix Medical and 1 mentions for Check-Cap. Check-Cap's average media sentiment score of 0.00 beat Autonomix Medical's score of -0.50 indicating that Check-Cap is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Autonomix Medical	0 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Negative
Check-Cap	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Autonomix Medical has a beta of -1.43, indicating that its share price is 243% less volatile than the broader market. Comparatively, Check-Cap has a beta of 0.59, indicating that its share price is 41% less volatile than the broader market.

10.8% of Autonomix Medical shares are held by institutional investors. Comparatively, 1.1% of Check-Cap shares are held by institutional investors. 6.2% of Autonomix Medical shares are held by company insiders. Comparatively, 0.5% of Check-Cap shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Check-Cap's return on equity of 0.00% beat Autonomix Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Autonomix Medical	N/A	-239.36%	-192.46%
Check-Cap	N/A	N/A	N/A

Summary

Check-Cap beats Autonomix Medical on 7 of the 13 factors compared between the two stocks.

How does Autonomix Medical compare to Quoin Pharmaceuticals?

Autonomix Medical (NASDAQ:AMIX) and Quoin Pharmaceuticals (NASDAQ:QNRX) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, media sentiment, institutional ownership, earnings, profitability and dividends.

Autonomix Medical's return on equity of -239.36% beat Quoin Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Autonomix Medical	N/A	-239.36%	-192.46%
Quoin Pharmaceuticals	N/A	-489.85%	-221.29%

Autonomix Medical presently has a consensus price target of $42.00, suggesting a potential upside of 482.52%. Given Autonomix Medical's higher probable upside, research analysts plainly believe Autonomix Medical is more favorable than Quoin Pharmaceuticals.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Autonomix Medical	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Quoin Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Autonomix Medical has a beta of -1.43, suggesting that its share price is 243% less volatile than the broader market. Comparatively, Quoin Pharmaceuticals has a beta of 1.56, suggesting that its share price is 56% more volatile than the broader market.

Autonomix Medical is trading at a lower price-to-earnings ratio than Quoin Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Autonomix Medical	N/A	N/A	-$16.72M	-$3.55	N/A
Quoin Pharmaceuticals	N/A	N/A	-$15.81M	-$29.56	N/A

In the previous week, Autonomix Medical had 2 more articles in the media than Quoin Pharmaceuticals. MarketBeat recorded 6 mentions for Autonomix Medical and 4 mentions for Quoin Pharmaceuticals. Quoin Pharmaceuticals' average media sentiment score of 0.00 beat Autonomix Medical's score of -0.50 indicating that Quoin Pharmaceuticals is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Autonomix Medical	0 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Negative
Quoin Pharmaceuticals	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

10.8% of Autonomix Medical shares are held by institutional investors. Comparatively, 8.6% of Quoin Pharmaceuticals shares are held by institutional investors. 6.2% of Autonomix Medical shares are held by insiders. Comparatively, 13.5% of Quoin Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

Autonomix Medical beats Quoin Pharmaceuticals on 6 of the 11 factors compared between the two stocks.

How does Autonomix Medical compare to Sintx Technologies?

Sintx Technologies (NASDAQ:SINT) and Autonomix Medical (NASDAQ:AMIX) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, institutional ownership, media sentiment, risk, dividends, analyst recommendations, profitability and earnings.

18.4% of Sintx Technologies shares are held by institutional investors. Comparatively, 10.8% of Autonomix Medical shares are held by institutional investors. 4.1% of Sintx Technologies shares are held by company insiders. Comparatively, 6.2% of Autonomix Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Autonomix Medical has a net margin of 0.00% compared to Sintx Technologies' net margin of -1,058.60%. Autonomix Medical's return on equity of -239.36% beat Sintx Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sintx Technologies	-1,058.60%	-366.49%	-115.04%
Autonomix Medical	N/A	-239.36%	-192.46%

Sintx Technologies has higher revenue and earnings than Autonomix Medical. Autonomix Medical is trading at a lower price-to-earnings ratio than Sintx Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sintx Technologies	$1.02M	8.30	-$10.36M	-$5.07	N/A
Autonomix Medical	N/A	N/A	-$16.72M	-$3.55	N/A

Sintx Technologies has a beta of 0.66, meaning that its stock price is 34% less volatile than the broader market. Comparatively, Autonomix Medical has a beta of -1.43, meaning that its stock price is 243% less volatile than the broader market.

In the previous week, Autonomix Medical had 5 more articles in the media than Sintx Technologies. MarketBeat recorded 6 mentions for Autonomix Medical and 1 mentions for Sintx Technologies. Sintx Technologies' average media sentiment score of 0.00 beat Autonomix Medical's score of -0.50 indicating that Sintx Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Sintx Technologies	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Autonomix Medical	0 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Negative

Sintx Technologies presently has a consensus target price of $9.33, suggesting a potential upside of 376.19%. Autonomix Medical has a consensus target price of $42.00, suggesting a potential upside of 482.52%. Given Autonomix Medical's higher possible upside, analysts plainly believe Autonomix Medical is more favorable than Sintx Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sintx Technologies	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50
Autonomix Medical	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

Sintx Technologies beats Autonomix Medical on 9 of the 15 factors compared between the two stocks.

How does Autonomix Medical compare to Allurion Technologies?

Autonomix Medical (NASDAQ:AMIX) and Allurion Technologies (NYSE:ALUR) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, media sentiment, valuation, dividends, risk, institutional ownership, analyst recommendations and profitability.

Autonomix Medical currently has a consensus price target of $42.00, suggesting a potential upside of 482.52%. Allurion Technologies has a consensus price target of $45.00, suggesting a potential upside of 7,658.62%. Given Allurion Technologies' higher possible upside, analysts plainly believe Allurion Technologies is more favorable than Autonomix Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Autonomix Medical	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Allurion Technologies	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

10.8% of Autonomix Medical shares are held by institutional investors. Comparatively, 21.4% of Allurion Technologies shares are held by institutional investors. 6.2% of Autonomix Medical shares are held by insiders. Comparatively, 8.1% of Allurion Technologies shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

In the previous week, Autonomix Medical had 5 more articles in the media than Allurion Technologies. MarketBeat recorded 6 mentions for Autonomix Medical and 1 mentions for Allurion Technologies. Allurion Technologies' average media sentiment score of -0.18 beat Autonomix Medical's score of -0.50 indicating that Allurion Technologies is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Autonomix Medical	0 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Negative
Allurion Technologies	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Allurion Technologies has higher revenue and earnings than Autonomix Medical. Autonomix Medical is trading at a lower price-to-earnings ratio than Allurion Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Autonomix Medical	N/A	N/A	-$16.72M	-$3.55	N/A
Allurion Technologies	$17.21M	0.51	-$7.20M	-$2.03	N/A

Autonomix Medical has a beta of -1.43, meaning that its stock price is 243% less volatile than the broader market. Comparatively, Allurion Technologies has a beta of -0.13, meaning that its stock price is 113% less volatile than the broader market.

Autonomix Medical has a net margin of 0.00% compared to Allurion Technologies' net margin of -199.96%. Allurion Technologies' return on equity of 0.00% beat Autonomix Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Autonomix Medical	N/A	-239.36%	-192.46%
Allurion Technologies	-199.96%	N/A	-77.13%

Summary

Allurion Technologies beats Autonomix Medical on 11 of the 13 factors compared between the two stocks.

How does Autonomix Medical compare to Nexalin Technology?

Nexalin Technology (NASDAQ:NXL) and Autonomix Medical (NASDAQ:AMIX) are both small-cap medical equipment companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, risk, analyst recommendations, earnings, dividends, media sentiment, profitability and institutional ownership.

0.6% of Nexalin Technology shares are held by institutional investors. Comparatively, 10.8% of Autonomix Medical shares are held by institutional investors. 25.3% of Nexalin Technology shares are held by company insiders. Comparatively, 6.2% of Autonomix Medical shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Nexalin Technology has higher revenue and earnings than Autonomix Medical. Autonomix Medical is trading at a lower price-to-earnings ratio than Nexalin Technology, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nexalin Technology	$275.58K	25.00	-$8.22M	-$0.47	N/A
Autonomix Medical	N/A	N/A	-$16.72M	-$3.55	N/A

Autonomix Medical has a net margin of 0.00% compared to Nexalin Technology's net margin of -3,018.12%. Nexalin Technology's return on equity of -191.88% beat Autonomix Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nexalin Technology	-3,018.12%	-191.88%	-166.43%
Autonomix Medical	N/A	-239.36%	-192.46%

Autonomix Medical has a consensus price target of $42.00, indicating a potential upside of 482.52%. Given Autonomix Medical's stronger consensus rating and higher possible upside, analysts clearly believe Autonomix Medical is more favorable than Nexalin Technology.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nexalin Technology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Autonomix Medical	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Nexalin Technology has a beta of 3.8, meaning that its stock price is 280% more volatile than the broader market. Comparatively, Autonomix Medical has a beta of -1.43, meaning that its stock price is 243% less volatile than the broader market.

In the previous week, Autonomix Medical had 4 more articles in the media than Nexalin Technology. MarketBeat recorded 6 mentions for Autonomix Medical and 2 mentions for Nexalin Technology. Nexalin Technology's average media sentiment score of 0.36 beat Autonomix Medical's score of -0.50 indicating that Nexalin Technology is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Nexalin Technology	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Autonomix Medical	0 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Negative

Summary

Nexalin Technology beats Autonomix Medical on 9 of the 15 factors compared between the two stocks.

Get Autonomix Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AMIX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

AMIX vs. The Competition

Export

Metric	Autonomix Medical	MED INSTRUMENTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$49.82M	$7.19B	$6.56B	$12.24B
Dividend Yield	N/A	1.27%	2.69%	5.82%
P/E Ratio	-2.03	49.00	25.17	23.98
Price / Sales	N/A	87.22	553.76	120.62
Price / Cash	N/A	24.78	44.82	54.51
Price / Book	8.48	7.31	10.76	6.41
Net Income	-$16.72M	$159.20M	$3.56B	$337.14M
7 Day Performance	-11.74%	0.09%	1.37%	-0.48%
1 Month Performance	-13.95%	-0.54%	0.81%	0.49%
1 Year Performance	-72.75%	5.77%	30.53%	28.16%

Autonomix Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
AMIX Autonomix Medical	1.8048 of 5 stars	$7.21 -4.4%	$42.00 +482.5%	-73.2%	$49.82M	N/A	N/A	1	Analyst Upgrade High Trading Volume
MBAI Check-Cap	0.427 of 5 stars	$1.36 flat	N/A	N/A	$9.91M	N/A	N/A	80
QNRX Quoin Pharmaceuticals	1.1809 of 5 stars	$4.62 +3.6%	N/A	-62.1%	$9.29M	N/A	N/A	4	News Coverage Gap Up Trading Halted
SINT Sintx Technologies	2.8663 of 5 stars	$2.08 -3.7%	$9.33 +348.7%	-37.5%	$8.98M	$738K	N/A	40
ALUR Allurion Technologies	1.4745 of 5 stars	$0.58 -1.7%	$3.00 +417.2%	-98.4%	$8.70M	$17.21M	N/A	501

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:AMIX) was last updated on 6/24/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Autonomix Medical (AMIX) Competitors

AMIX vs. MBAI, QNRX, SINT, ALUR, and NXL

How does Autonomix Medical compare to Check-Cap?

Summary

How does Autonomix Medical compare to Quoin Pharmaceuticals?

Summary

How does Autonomix Medical compare to Sintx Technologies?

Summary

How does Autonomix Medical compare to Allurion Technologies?

Summary

How does Autonomix Medical compare to Nexalin Technology?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AMIX vs. The Competition

Autonomix Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Autonomix Medical (AMIX) Competitors

AMIX vs. MBAI, QNRX, SINT, ALUR, and NXL

How does Autonomix Medical compare to Check-Cap?

Which has better earnings & valuation, AMIX or MBAI?

Do analysts rate AMIX or MBAI?

Does the media favor AMIX or MBAI?

Which has more risk & volatility, AMIX or MBAI?

Do institutionals and insiders believe in AMIX or MBAI?

Is AMIX or MBAI more profitable?

Summary

How does Autonomix Medical compare to Quoin Pharmaceuticals?

Is AMIX or QNRX more profitable?

Do analysts rate AMIX or QNRX?

Which has more volatility & risk, AMIX or QNRX?

Which has stronger valuation & earnings, AMIX or QNRX?

Does the media prefer AMIX or QNRX?

Do institutionals & insiders hold more shares of AMIX or QNRX?

Summary

How does Autonomix Medical compare to Sintx Technologies?

Do institutionals and insiders hold more shares of SINT or AMIX?

Is SINT or AMIX more profitable?

Which has better earnings & valuation, SINT or AMIX?

Which has more volatility & risk, SINT or AMIX?

Does the media refer more to SINT or AMIX?

Do analysts prefer SINT or AMIX?

Summary

How does Autonomix Medical compare to Allurion Technologies?

Do analysts prefer AMIX or ALUR?

Do institutionals & insiders hold more shares of AMIX or ALUR?

Does the media refer more to AMIX or ALUR?

Which has higher valuation & earnings, AMIX or ALUR?

Which has more risk and volatility, AMIX or ALUR?

Is AMIX or ALUR more profitable?

Summary

How does Autonomix Medical compare to Nexalin Technology?

Do insiders & institutionals have more ownership in NXL or AMIX?

Which has preferable valuation & earnings, NXL or AMIX?

Is NXL or AMIX more profitable?

Do analysts recommend NXL or AMIX?

Which has more volatility & risk, NXL or AMIX?

Does the media favor NXL or AMIX?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AMIX vs. The Competition

Autonomix Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools